@DrJackKruse: Let me fix this tweet. Peat t...
@DrJackKruse
54 views
Aug 29, 2025
1
Let me fix this tweet. Peat taught Moosa to regurgitate: "When people used aspirin, their tissue conversion of T4 to the active form T3 was significantly increased" That is because apirin degrades melanin. And melanin degradation is a consequence of the action of aspirin. What are the implications of this "Moosa miss?"
In essence, my work I shared with Peat reframes Peat's insight through a quantum lens: Aspirin doesn't just unbind hormones; it reallocates melanin precursors under light's quantum guidance, enhancing T3. Mastering this requires embracing the full spectrum of light and knowledge that is known, literally and figuratively, to avoid the pitfalls of partial knowledge.
Building the Case: Aspirin's Role in Enhancing T4 to T3 Conversion via Melanin Degradation and Pathway Shunting
Ray Peat's observation, that aspirin (acetylsalicylic acid, or ASA) significantly increases tissue conversion of thyroxine (T4) to the active triiodothyronine (T3) is well-supported by studies showing salicylates elevate free T3 levels in human serum. However, the conventional centralized explanation focuses on aspirin's inhibition of thyroid hormone binding to proteins like thyroxine-binding prealbumin (TBPA) and thyroxine-binding globulin (TBG), which frees up more T3 and T4 for circulation and potentially enhances peripheral deiodination (the enzymatic removal of iodine from T4 to form T3). While this mechanism is accurate, it represents only a partial view of reality happening inside cells.
My decentralized work on light and oxygen from the GOE has revealed that this effect occurs because aspirin degrades melanin, thereby redirecting precursors toward thyroid hormone synthesis. Moreover, this aligns with recent NEW emerging insights that happened during Peats life and he ignored when I shared it with him into shared biochemical pathways and quantum biological influences, as illustrated in the provided slide on UV-A light controlling melanin renovations in mammals.
Let's construct this case step by step, drawing on the slide's depiction of aromatic amino acid pathways (e.g., phenylalanine → tyrosine → precursors branching to T3/T4 or DOPA/melanin) and supporting evidence.
1. Shared Biosynthetic Pathways: Tyrosine as the Common Hub for Melanin and Thyroid Hormones Both melanin and thyroid hormones (T3 and T4) originate from the aromatic amino acid tyrosine, as shown in the slide's top line: Phenylalanine → Tyrosine → Precursor → T3, T4 (with a branch to DOPA → Dopamine/Adrenalin/Noradrenalin/Melanin).
Thyroid hormones are synthesized in the thyroid gland via iodination of tyrosine residues in thyroglobulin, leading to monoiodotyrosine (MIT) and diiodotyrosine (DIT), which couple to form T3 and T4.
Melanin, conversely, is produced from tyrosine through oxidation by tyrosinase to form DOPA (dihydroxyphenylalanine), then dopaquinone, and eventually eumelanin or pheomelanin in melanocytes.
This bifurcation means resources (tyrosine and downstream intermediates) are competitively allocated. If melanin production is upregulated, less tyrosine may be available for thyroid hormone synthesis, and vice versa. Studies confirm thyroid hormones regulate pigment cell maturation and melanin synthesis in models like zebrafish and frogs, where thyroid hormone promotes melanophore differentiation but limits cell proliferation, suggesting a reciprocal relationship. Disruptions in melanin-concentrating hormone (MCH) signaling also alter thyroid function, linking pigmentation control to the hypothalamic-pituitary-thyroid (HPT) axis.
In conditions like hypothyroidism, skin pigmentation changes (e.g., melasma) occur due to hormonal imbalances, further illustrating the interplay.
2. Aspirin's Action on Melanin: Inhibition of Synthesis and Potential Degradation
Aspirin and its metabolite salicylate inhibit melanogenesis by downregulating tyrosinase expression and activity, the rate-limiting enzyme in melanin production. For instance, ASA suppresses prostaglandin E2 (PGE2) and activates AMP kinase, reducing melanin synthesis in melanocytes without causing oxidative stress or cell death.
While direct "degradation" of existing melanin isn't explicitly termed in literature, inhibiting synthesis accelerates melanin turnover (natural breakdown and excretion), effectively reducing melanin levels over time. This is akin to how anti-melanogenic agents like arbutin work, and ASA has been shown to inhibit alpha-MSH-enhanced melanin more potently than arbutin.📷By curbing the melanin branch of the pathway, aspirin could shunt tyrosine and DOPA-like intermediates back toward the thyroid hormone arm. The slide's depiction of a "precursor" stage before branching to T3/T4 or DOPA/melanin supports this: Reducing flux to melanin frees resources for iodination and T4/T3 formation.
If melanin inhibition liberates precursors, this could amplify deiodination, explaining Peat's observation beyond mere binding effects.
Evidence for enhanced T4 to T3 conversion: Salicylates increase free T3 by 20-30% in serum, partly via protein displacement but also suggesting boosted peripheral deiodinase activity.
3. The Quantum Biology Layer: Light's Role in Directing Pathways and Neural Regulation The slide below I have posted hundreds of times emphasizes that neuropsin (an O2/light sensor) drives the reaction "left or right," with 380 nm UV-A light controlling neuropsin, mTOR, DHA catabolism, and melanin renovations. This highlights quantum effects where light photons interact with aromatic amino acids (phenylalanine, tyrosine, tryptophan) via their absorption/emission spectra. This was all innovated in the GOE, which Peat never mentioned in his life.
Aromatic amino acids absorb UV light around 250-300 nm (peaks at ~280 nm for Tyr/Trp), leading to charge transfer transitions (ProCharTS) and fluorescence emission. In quantum biology, these spectra enable electron/proton tunneling and energy transfer, influencing enzyme kinetics and signaling. I showed Peat papers on this and he just looked at me with a blank stare. He had no answers for his myopia.
Light entrains the hypothalamic-pituitary-adrenal (HPA) and HPT axes via retinal and skin photoreceptors (e.g., melanopsin, neuropsin), modulating hormone release. UV light stimulates the hypothalamus via nitric oxide pathways, affecting cortisol, thyroid, and melanin-related hormones. Tryptophan networks exhibit quantum coherence, potentially defending against brain diseases by maintaining rhythmic signaling.
Aspirin's melanin inhibition enhances light sensitivity in these pathways, as reduced melanin (a light absorber) allows more UV-A penetration to neuropsin, shifting the balance toward T3/T4 production under hypoxia or stress conditions (as per the slide's hypoxia arrow).
Expanding on Half-Truths Leading to Full Lies: The Perils of Ignoring Quantum Light Effects Half-truths in science where statements that are partially correct but omit critical contexts, often snowball into full lies by fostering incomplete models that misguide research, treatments, and understanding. In this case, the half-truth is the conventional focus on aspirin's biochemical effects (e.g., protein binding inhibition or cyclooxygenase blockade) without integrating quantum biology's role in light-matter interactions.
The Cascade from Omission to Misrepresentation: Starting with a half-truth like "aspirin boosts T3 by freeing it from proteins" ignores the upstream pathway shunting via melanin inhibition. This leads to a full lie: assuming thyroid optimization is purely enzymatic or hormonal, without considering environmental light as a regulator. For instance, if light's absorption by tyrosine (at ~280 nm) drives quantum tunneling in deiodinases or neuropsin, missing this means therapies overlook chronobiology, e.g., aspirin's efficacy might vary by light exposure, leading to inconsistent clinical outcomes.
Half-truths propagate through education and policy, leading to "full lies" like overprescribing synthroid without addressing light hygiene, perpetuating cycles of incomplete healing.
Quantum Blind Spots in Neural Tracts: The corticotropin-releasing hormone (CRH) tracts, hypothalamus, and pituitary axis rely on quantum effects for precision. Aromatic amino acids in neurotransmitters (e.g., tyrosine in dopamine, tryptophan in serotonin/melatonin) absorb/emit light, enabling coherent energy transfer that synchronizes rhythms. Peat's career work as a biochemist was to ignore this "power of light" and this is why he created a full lie for his audience: viewing the HPA/HPT axes as classical mechanical systems, not quantum sensors responsive to spectra. This results in flawed models of disorders like hypothyroidism or adrenal fatigue, where light dysregulation (e.g., blue light excess) disrupts melatonin (from tryptophan) and cascades to thyroid imbalance. If you are a Peatatarian you are to be avoided and mocked by light gurus. I told him that if he did not adapt his template to these ideas I would eviscerate his work. That promise is now reality in this thread. Never settle for bullshit.
In essence, my work I shared with Peat reframes Peat's insight through a quantum lens: Aspirin doesn't just unbind hormones; it reallocates melanin precursors under light's quantum guidance, enhancing T3. Mastering this requires embracing the full spectrum of light and knowledge that is known, literally and figuratively, to avoid the pitfalls of partial knowledge.
Building the Case: Aspirin's Role in Enhancing T4 to T3 Conversion via Melanin Degradation and Pathway Shunting
Ray Peat's observation, that aspirin (acetylsalicylic acid, or ASA) significantly increases tissue conversion of thyroxine (T4) to the active triiodothyronine (T3) is well-supported by studies showing salicylates elevate free T3 levels in human serum. However, the conventional centralized explanation focuses on aspirin's inhibition of thyroid hormone binding to proteins like thyroxine-binding prealbumin (TBPA) and thyroxine-binding globulin (TBG), which frees up more T3 and T4 for circulation and potentially enhances peripheral deiodination (the enzymatic removal of iodine from T4 to form T3). While this mechanism is accurate, it represents only a partial view of reality happening inside cells.
My decentralized work on light and oxygen from the GOE has revealed that this effect occurs because aspirin degrades melanin, thereby redirecting precursors toward thyroid hormone synthesis. Moreover, this aligns with recent NEW emerging insights that happened during Peats life and he ignored when I shared it with him into shared biochemical pathways and quantum biological influences, as illustrated in the provided slide on UV-A light controlling melanin renovations in mammals.
Let's construct this case step by step, drawing on the slide's depiction of aromatic amino acid pathways (e.g., phenylalanine → tyrosine → precursors branching to T3/T4 or DOPA/melanin) and supporting evidence.
1. Shared Biosynthetic Pathways: Tyrosine as the Common Hub for Melanin and Thyroid Hormones Both melanin and thyroid hormones (T3 and T4) originate from the aromatic amino acid tyrosine, as shown in the slide's top line: Phenylalanine → Tyrosine → Precursor → T3, T4 (with a branch to DOPA → Dopamine/Adrenalin/Noradrenalin/Melanin).
Thyroid hormones are synthesized in the thyroid gland via iodination of tyrosine residues in thyroglobulin, leading to monoiodotyrosine (MIT) and diiodotyrosine (DIT), which couple to form T3 and T4.
Melanin, conversely, is produced from tyrosine through oxidation by tyrosinase to form DOPA (dihydroxyphenylalanine), then dopaquinone, and eventually eumelanin or pheomelanin in melanocytes.
This bifurcation means resources (tyrosine and downstream intermediates) are competitively allocated. If melanin production is upregulated, less tyrosine may be available for thyroid hormone synthesis, and vice versa. Studies confirm thyroid hormones regulate pigment cell maturation and melanin synthesis in models like zebrafish and frogs, where thyroid hormone promotes melanophore differentiation but limits cell proliferation, suggesting a reciprocal relationship. Disruptions in melanin-concentrating hormone (MCH) signaling also alter thyroid function, linking pigmentation control to the hypothalamic-pituitary-thyroid (HPT) axis.
In conditions like hypothyroidism, skin pigmentation changes (e.g., melasma) occur due to hormonal imbalances, further illustrating the interplay.
2. Aspirin's Action on Melanin: Inhibition of Synthesis and Potential Degradation
Aspirin and its metabolite salicylate inhibit melanogenesis by downregulating tyrosinase expression and activity, the rate-limiting enzyme in melanin production. For instance, ASA suppresses prostaglandin E2 (PGE2) and activates AMP kinase, reducing melanin synthesis in melanocytes without causing oxidative stress or cell death.
While direct "degradation" of existing melanin isn't explicitly termed in literature, inhibiting synthesis accelerates melanin turnover (natural breakdown and excretion), effectively reducing melanin levels over time. This is akin to how anti-melanogenic agents like arbutin work, and ASA has been shown to inhibit alpha-MSH-enhanced melanin more potently than arbutin.📷By curbing the melanin branch of the pathway, aspirin could shunt tyrosine and DOPA-like intermediates back toward the thyroid hormone arm. The slide's depiction of a "precursor" stage before branching to T3/T4 or DOPA/melanin supports this: Reducing flux to melanin frees resources for iodination and T4/T3 formation.
If melanin inhibition liberates precursors, this could amplify deiodination, explaining Peat's observation beyond mere binding effects.
Evidence for enhanced T4 to T3 conversion: Salicylates increase free T3 by 20-30% in serum, partly via protein displacement but also suggesting boosted peripheral deiodinase activity.
3. The Quantum Biology Layer: Light's Role in Directing Pathways and Neural Regulation The slide below I have posted hundreds of times emphasizes that neuropsin (an O2/light sensor) drives the reaction "left or right," with 380 nm UV-A light controlling neuropsin, mTOR, DHA catabolism, and melanin renovations. This highlights quantum effects where light photons interact with aromatic amino acids (phenylalanine, tyrosine, tryptophan) via their absorption/emission spectra. This was all innovated in the GOE, which Peat never mentioned in his life.
Aromatic amino acids absorb UV light around 250-300 nm (peaks at ~280 nm for Tyr/Trp), leading to charge transfer transitions (ProCharTS) and fluorescence emission. In quantum biology, these spectra enable electron/proton tunneling and energy transfer, influencing enzyme kinetics and signaling. I showed Peat papers on this and he just looked at me with a blank stare. He had no answers for his myopia.
Light entrains the hypothalamic-pituitary-adrenal (HPA) and HPT axes via retinal and skin photoreceptors (e.g., melanopsin, neuropsin), modulating hormone release. UV light stimulates the hypothalamus via nitric oxide pathways, affecting cortisol, thyroid, and melanin-related hormones. Tryptophan networks exhibit quantum coherence, potentially defending against brain diseases by maintaining rhythmic signaling.
Aspirin's melanin inhibition enhances light sensitivity in these pathways, as reduced melanin (a light absorber) allows more UV-A penetration to neuropsin, shifting the balance toward T3/T4 production under hypoxia or stress conditions (as per the slide's hypoxia arrow).
Expanding on Half-Truths Leading to Full Lies: The Perils of Ignoring Quantum Light Effects Half-truths in science where statements that are partially correct but omit critical contexts, often snowball into full lies by fostering incomplete models that misguide research, treatments, and understanding. In this case, the half-truth is the conventional focus on aspirin's biochemical effects (e.g., protein binding inhibition or cyclooxygenase blockade) without integrating quantum biology's role in light-matter interactions.
The Cascade from Omission to Misrepresentation: Starting with a half-truth like "aspirin boosts T3 by freeing it from proteins" ignores the upstream pathway shunting via melanin inhibition. This leads to a full lie: assuming thyroid optimization is purely enzymatic or hormonal, without considering environmental light as a regulator. For instance, if light's absorption by tyrosine (at ~280 nm) drives quantum tunneling in deiodinases or neuropsin, missing this means therapies overlook chronobiology, e.g., aspirin's efficacy might vary by light exposure, leading to inconsistent clinical outcomes.
Half-truths propagate through education and policy, leading to "full lies" like overprescribing synthroid without addressing light hygiene, perpetuating cycles of incomplete healing.
Quantum Blind Spots in Neural Tracts: The corticotropin-releasing hormone (CRH) tracts, hypothalamus, and pituitary axis rely on quantum effects for precision. Aromatic amino acids in neurotransmitters (e.g., tyrosine in dopamine, tryptophan in serotonin/melatonin) absorb/emit light, enabling coherent energy transfer that synchronizes rhythms. Peat's career work as a biochemist was to ignore this "power of light" and this is why he created a full lie for his audience: viewing the HPA/HPT axes as classical mechanical systems, not quantum sensors responsive to spectra. This results in flawed models of disorders like hypothyroidism or adrenal fatigue, where light dysregulation (e.g., blue light excess) disrupts melatonin (from tryptophan) and cascades to thyroid imbalance. If you are a Peatatarian you are to be avoided and mocked by light gurus. I told him that if he did not adapt his template to these ideas I would eviscerate his work. That promise is now reality in this thread. Never settle for bullshit.
View Tweet
